Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia

BACKGROUND: The positive transcription elongation factor b (P-TEFb) kinase activity is involved in the process of transcription. Cyclin-dependent kinase 9 (CDK9), a core component of P-TEFb, regulates the process of transcription elongation, which is associated with differentiation and apoptosis in...

Descripción completa

Detalles Bibliográficos
Autores principales: Qing, Yingjie, Wang, Xiangyuan, Wang, Hongzheng, Hu, Po, Li, Hui, Yu, Xiaoxuan, Zhu, Mengyuan, Wang, Zhanyu, Zhu, Yu, Xu, Jingyan, Guo, Qinglong, Hui, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351106/
https://www.ncbi.nlm.nih.gov/pubmed/34372855
http://dx.doi.org/10.1186/s12964-021-00764-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351106/
https://www.ncbi.nlm.nih.gov/pubmed/34372855
http://dx.doi.org/10.1186/s12964-021-00764-5

Ejemplares similares